Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by 5,000+ Wall Street analysts over the past 3-months

#	Name	Upside %	Analysts bullish %
26	26 Gossamer Bio GOSS $398M	338% upside 3 price targets	0
27	27 Kura Oncology KURA $574M	337% upside 5 price targets	0
28	28 Lucid Diagnostics LUCD $124M	270% upside 3 price targets	0
29	29 Structure Therapeutics GPCR $1.12B	270% upside 4 price targets	0
30	30 Dyne Therapeutics DYN $1.35B	267% upside 8 price targets	0
31	31 Lexeo Therapeutics LXEO $222M	264% upside 3 price targets	0
32	TECX 32 Tectonic Therapeutic, Inc. Common Stock TECX $428M	261% upside 3 price targets	0
33	33 Arcturus Therapeutics ARCT $373M	254% upside 3 price targets	0
34	34 Pulmonx LUNG $132M	243% upside 4 price targets	0
35	35 Trevi Therapeutics TRVI $825M	236% upside 4 price targets	0
36	36 Immuneering IMRX $146M	226% upside 4 price targets	0
37	37 Edgewise Therapeutics EWTX $1.46B	220% upside 3 price targets	0
38	38 PolyPid PYPD $38.2M	220% upside 3 price targets	0
39	39 Taysha Gene Therapies TSHA $670M	219% upside 6 price targets	0
40	40 ProQR Therapeutics PRQR $252M	214% upside 4 price targets	0
41	41 Y-mAbs Therapeutics YMAB $198M	205% upside 3 price targets	0
42	42 Cardiff Oncology CRDF $298M	201% upside 3 price targets	0
43	43 Abeona Therapeutics ABEO $335M	201% upside 3 price targets	0
44	44 Biohaven BHVN $1.52B	198% upside 3 price targets	0
45	45 Viking Therapeutics VKTX $3.62B	197% upside 4 price targets	0
46	46 uniQure QURE $855M	190% upside 3 price targets	0
47	HIVE 47 HIVE Digital Technologies HIVE $450M	188% upside 4 price targets	0
48	48 Vir Biotechnology VIR $759M	185% upside 3 price targets	0
49	49 Intellia Therapeutics NTLA $1.23B	185% upside 7 price targets	0
50	50 Perspective Therapeutics CATX $306M	185% upside 4 price targets	0

12345

65